RSS
Bavarian Nordic
J&J Ebola vaccine: "Every day counts"
Johnson & Johnson has accelerated its Phase 1, first-in-human clinical trial of a preventive Ebola vaccine, with Chief Scientific Officer Paul Stoffels stating "every day counts". more
Bavarian Nordic announces first patient treated in a phase I study of MVA-BN Brachyury in advanced cancer
This immunotherapy is designed to induce a robust immune response against Brachyury, a tumour-associated antigen which is overexpressed in every major solid tumour setting more
